Chair: Welcome back. Thailand: Thank you Madam Chair. Unfortunately we did not manage to agree on any further PPs although we made some progress but it seems some of the delegation were holding onto some of the paragraphs to see the outcomes of the others. For now this morning we had PP11 written as agreed …
Brazil
Item 3. High-level segment (Friday afternoon)
Bangladesh: H. E. Ambassador Johnson, Chair of the Commission on Narcotic Drugs at its 67th Session, H. E. Ghada Waly, Executive Director of the UNODC, Excellencies, Distinguished delegates, Ladies and Gentlemen, Good afternoon. I begin by congratulating Ambassador Johnson and other members of the bureau and assure them of our full support. Mr. Chair, We …
Round Table – Taking Stock: Work Undertaken Since 2019
UN Web TV recording ;Bangladesh/Chair: Discuss the work done around the globe to implement drug control commitments – identify progress, identify challenges. This will consist of a panel of interventions followed by interactive discussions. Mexico/Co-Chair: Delegations wishing to take the floor can raise their panels to nominate themselves. Please bear with me if I call …
Opening of the 67th session of the Commission on Narcotic Drugs & Item 3. High-level segment (Thursday morning)
UN Web TV recording Opening of the 67th session of the Commission on Narcotic DrugsOutcome Document: High-level Declaration by the Commission on Narcotic Drugs on the 2024 midterm review, following up to the 2019 Ministerial DeclarationChair: Welcome. Inform you that for the opening session of the HLS, there’ll be a video transmission of the …
CND Tematic Discussion / Session 12 – Way Forward
Chair: I am grateful for your cooperation earlier this year. We had previously discussed the Resolution, outlining the review process, and collectively decided to convene before he regular committee session. The high-level segment is scheduled for March 14th and 15th, dedicated to assessing the implementation of international drug policy commitments. During this segment, we aim …
CND Thematic Discussion / Session 11 – Low availability of internationally controlled substances for medical & scientific purposes
Chair: Good Morning. Yesterday we had a fruitful discussion on the issues of the consequences and risk associated with non medical use of drugs. Today we will be discussing the low availability of nationally controlled substances for medical and scientific purposes, including for the relief of pain and palliative care. Before we start a discussion, …